Avior Wealth Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$524K Buy
4,913
+919
+23% +$111K 0.01% 507
2026
Q1
$653K Buy
3,994
+1,622
+68% +$249K 0.02% 459
2025
Q4
$413K Sell
2,372
-781
-25% -$143K 0.01% 519
2025
Q3
$454K Sell
3,153
-999
-24% -$122K 0.01% 472
2025
Q2
$418K Buy
4,152
+1
+0% +$76 0.01% 482
2025
Q1
$317K Buy
4,151
+1,873
+82% +$143K 0.01% 530
2024
Q4
$157K Buy
+2,278
New +$164K 0.01% 775
2024
Q2
Sell
-138
Closed -$3.74K 2977
2024
Q1
$3.74K Buy
+138
New +$3.86K ﹤0.01% 2153
2021
Q4
Sell
-46
Closed -$1K 1156
2021
Q3
$1K Hold
46
﹤0.01% 1000
2021
Q2
$1K Buy
+46
New +$1.36K ﹤0.01% 972

Other funds holding INSM

Avior Wealth Management's INSM Position: Q2 2026 in Review

Avior Wealth Management increased its Insmed (INSM) stake by 23% in Q2 2026, buying an estimated $111K and bringing the position to 4,913 shares worth $524K. The position accounts for 0.01% of the portfolio, ranked #507.

Avior Wealth Management first reported a position in INSM in Q2 2021 and has held it in 10 quarters since. The position peaked at $653K in Q1 2026. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Avior Wealth Management held 4,913 shares of Insmed worth $524K as of Q2 2026.
  • Avior Wealth Management bought 919 Insmed shares in Q2 2026, an estimated $111K.
  • Insmed made up 0.01% of Avior Wealth Management's portfolio in Q2 2026, its #507 holding.
  • Avior Wealth Management first reported a position in Insmed in Q2 2021 and has held it in 10 quarters since.
  • Avior Wealth Management's Insmed position peaked at $653K in Q1 2026.
  • 664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.